We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEN
3801
DELISTED
ZENDESK INC
ZEN
– –
-183,619
Closed -$14M
IACC
3802
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
– –
-1,202,841
Closed -$11.9M
FSRD
3803
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
– –
-500,000
Closed -$200K
TEN
3804
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
– –
-888,119
Closed -$15.4M
GAPA
3805
DELISTED
G&P Acquisition Corp.
GAPA
– –
-859,458
Closed -$8.59M
TSPQ.WS
3806
CALL
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
– –
-651,181
Closed -$6.39M
AAQC.WS
3807
CALL
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
– –
-466,662
Closed -$4.64M
AXH
3808
DELISTED
Industrial Human Capital, Inc.
AXH
– –
-209,028
Closed -$2.12M
ESSCW
3809
CALL
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
– –
-269,000
Closed -$2.79M
HTPA.WS
3810
CALL
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
– –
-66,662
Closed -$664K
MDH.WS
3811
CALL
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
– –
-655,000
Closed -$6.51M
CRHC.WS
3812
CALL
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
– –
-395,785
Closed -$3.94M
NOAC
3813
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
– –
-196,384
Closed -$1.96M
NOACW
3814
CALL
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
– –
-220,152
Closed -$2.2M
SPGS.WS
3815
CALL
DELISTED
Simon Property Group Acquisition Holdings, Inc. Warrants, each exercisable for one Class A common stock at an exercise price of $11.50 per share
SPGS.WS
– –
-39,992
Closed -$395K
IS
3816
DELISTED
ironSource Ltd.
IS
– –
-1,931,979
Closed -$6.64M
HAAC
3817
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
– –
-2,377,359
Closed -$23.7M
HAACW
3818
CALL
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
– –
-349,998
Closed -$3.49M
CYBE
3819
DELISTED
Cyberoptics Corp
CYBE
– –
-8,391
Closed -$452K
AMPI.WS
3820
CALL
DELISTED
Advanced Merger Partners Inc Warrants
AMPI.WS
– –
-14,576
Closed -$143K
HTAQ
3821
DELISTED
Hunt Companies Acquisition Corp. I
HTAQ
– –
-99,998
Closed -$1.01M
CLIM.WS
3822
CALL
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
– –
-17,495
Closed -$175K
EDNCW
3823
CALL
DELISTED
Endurance Acquisition Corp. Warrant
EDNCW
– –
-309,012
Closed -$3.1M
EDNC
3824
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
– –
-835,331
Closed -$8.39M
LUXA
3825
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
– –
-1,378,941
Closed -$13.8M
151 152
153
154 155

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.